SurModics Stock Options Expiring on 17th of January

SRDX Stock  USD 28.30  0.02  0.07%   

SurModics Market Cap Over Time

   Market Cap   
       Timeline  

SurModics Total Stockholder Equity

Total Stockholder Equity

116.56 Million

At this time, SurModics' Total Stockholder Equity is fairly stable compared to the past year.

SurModics Corporate Management

Charles OlsonSr. VP and General Manager of Medical DeviceProfile
Timothy ArensVP of Corporate Devel. and StrategyProfile
Joseph StichVP and General Manager of In-Vitro DiagnosticsProfile
Gordon JDGeneral LegalProfile
Gordon WeberGeneral LegalProfile

Additional Tools for SurModics Stock Analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.